The estimated Net Worth of Iain Michael Brown is at least $5.12 Milion dollars as of 23 February 2024. Mr. Brown owns over 5,825 units of Alkermes plc stock worth over $3,159,997 and over the last 9 years he sold ALKS stock worth over $1,960,334. In addition, he makes $0 as Senior Vice President - Finance a Chief Accounting Officer at Alkermes plc.
Iain has made over 38 trades of the Alkermes plc stock since 2015, according to the Form 4 filled with the SEC. Most recently he exercised 5,825 units of ALKS stock worth $154,770 on 23 February 2024.
The largest trade he's ever made was exercising 40,000 units of Alkermes plc stock on 19 August 2021 worth over $662,000. On average, Iain trades about 5,896 units every 69 days since 2015. As of 23 February 2024 he still owns at least 118,931 units of Alkermes plc stock.
You can see the complete history of Mr. Brown stock trades at the bottom of the page.
Iain M. Brown is Senior Vice President - Finance, Chief Accounting Officer of the Company. Prior to assuming his current positions, Mr. Brown was our Chief Accounting Officer and Vice President, Finance, from May 2015 to May 2016. From September 16, 2011 to May 2015, Mr. Brown was our Vice President, Finance. From June 2006 to September 16, 2011, Mr. Brown served as Vice President, Finance of Alkermes, Inc. From March 2005 to June 2006, Mr. Brown served as Director of Finance of Alkermes, Inc. From July 2004 to March 2005, Mr. Brown served as Director of Financial Planning and Analysis of Alkermes, Inc. Mr. Brown joined Alkermes, Inc. in June 2003 as Associate Director of Financial Planning and Analysis. Prior to joining Alkermes, Inc., Mr. Brown was Vice President of Finance, North America at Serono, Inc.
Iain Brown is 51, he's been the Senior Vice President - Finance a Chief Accounting Officer of Alkermes plc since 2016. There are 18 older and 3 younger executives at Alkermes plc. The oldest executive at Alkermes plc is Dr. Floyd E. Bloom M.D., 84, who is the Founder.
Iain's mailing address filed with the SEC is 900, Winter Street, Prospectville, Waltham, Middlesex County, Massachusetts, 02451, United States.
Over the last 13 years, insiders at Alkermes plc have traded over $407,046,771 worth of Alkermes plc stock and bought 86,119 units worth $2,034,840 . The most active insiders traders include Corp Plc Elan Science Three..., Richard F Pops a James M Frates. On average, Alkermes plc executives and independent directors trade stock every 5 days with the average trade being worth of $1,083,232. The most recent stock trade was executed by David Joseph Gaffin on 3 August 2024, trading 2,014 units of ALKS stock currently worth $53,512.
alkermes plc is a fully integrated, global biopharmaceutical company developing innovative medicines for the treatment of central nervous system (cns) diseases. the company has a diversified commercial product portfolio and a substantial clinical pipeline of product candidates for chronic diseases that include schizophrenia, depression, addiction and multiple sclerosis. headquartered in dublin, ireland, alkermes plc has an r&d center in waltham, massachusetts; a research and manufacturing facility in athlone, ireland; and a manufacturing facility in wilmington, ohio. for more information, please visit alkermes’ website at www.alkermes.com.
Alkermes plc executives and other stock owners filed with the SEC include: